Qubit pharmaceuticals secures 16.1 million euros in seed round to revolutionize drug discovery
The Quantum Insider - 10-Jun-2022Developing a software platform that uses quantum computers to accelerate the discovery of new drugs
Previously the Live Forever Club — same community, now with a sharper mission for life extension
CEO of Qubit Pharmaceuticals
Robert Marino has a diverse work experience spanning multiple roles at industries, and is currently the CEO of Qubit Pharmaceuticals. Prior to that, they co-founded and served as CEO of Deeptech Founders. He worked at idfinnov as a Business Unit Director, where they were responsible for technology detection, seeding, and commercialization. Robert also held the role of Business Developer at idfinnov.
Overall, Robert Marino has a strong background in leadership, business development, and research, with a focus on innovation and technology commercialization.
Robert began his education at Lycée Saint Louis from 2003 to 2005. Robert then attended Chimie ParisTech - PSL from 2005 to 2008, where he obtained a Master of Science in Chemistry with a focus on Chemistry, Management, and Entrepreneurship. In 2007-2008, he also pursued a Master's degree in Applied Physics at Pierre and Marie Curie University. Continuing their educational journey, he pursued a PhD in Material Sciences from 2008 to 2011.
Visit website: https://www.qubit-pharmaceuticals.com/#RoberMarino
See alsoDetails last updated 21-Nov-2023
Developing a software platform that uses quantum computers to accelerate the discovery of new drugs